Scott at 19:52, 13 March 2007

2007-03-13T19:52:00Z

← Older revision		Revision as of 19:52, 13 March 2007
Line 1:		Line 1:
			{{Season1}}

	This is the [[Cognivia]] Shareholder Update presented at the begining of 269 to shareholders. We acquired it by way of [[Helix Hesh]], with some help from [[Tippy]].		This is the [[Cognivia]] Shareholder Update presented at the begining of 269 to shareholders. We acquired it by way of [[Helix Hesh]], with some help from [[Tippy]].

Scott at 21:03, 21 April 2006

2006-04-21T21:03:23Z

Show changes

Scott at 16:57, 21 April 2006

2006-04-21T16:57:36Z

New page

cnvc o g n i v i a

Shareholder
Update

March 269

cnvc o g n i v i a Shareholder Update 

March 269

a brighter
future

Cognivia is leaner, fitter and
better placed than ever. Over the past financial

year, our share of the cognitive
enhancement retail market increased from 68%

to 69%, leading to an increase in
turnover of 3.2%.

Coupled with our internal
efficiency programme and streamlined distribution

network, this gave us a 4.7% rise
in profits (before exceptional items).

Progress in
mind

Our investments in AI continue to
produce extremely promising results. Agilon

is on the verge of completing its
new City Behavioural Model, which will prove

invaluable to anyone wishing to
predict citizensʼ reactions to a huge variety of

stimuli – from natural disasters
to marketing campaigns.

Completing the
picture

In prosthetics, weʼre forging
ahead in our development of nanotechnology.

Within the year, we expect to have
completed the core work on our neural scanner,

which will allow us to map and
replicate the networks of any part of the

brain. It will soon be possible to
scan a healthy brain in its entirety and, if it is

damaged in later life, to recreate
a prosthesis of the damaged region.

The winning
formula

This year, we also continued our
successful association with the PCAG. The

exposure this gives Cognivia is a
key factor in our domination of the market,

and weʼve been working hard
to maintain our position as the PCAGʼs partner of

choice.

To keep up with the latest enhancement
and concealment techniques, our biodata

scans have been upgraded to
include a full genetic profile, highlighting any

signs of gene therapy. And as
cerebral prosthetics become more and more

sophisticated, weʼve
developed new methods for detecting and disabling nanotechnology.

-------

cnvc o g n i v i a Shareholder Update 

March 269

evolution,
accelerated

For millions of years, life has
been a missed opportunity. Generations of human

beings have been able to access
only a fraction of their mental capacity, never

reaching their full potential.

In the past twenty years, Cognivia
has taken the human mind to new levels. The

ability to enhance our own
faculties has heralded the start of a new evolutionary

era. Mankind has entered the Mind
Age.

The next
generation

And now, weʼre preparing to
take the next step in that evolution. Ceretin 6 is in

its final test phase, having
already shown significantly improved performance

over the current generation of
Ceretin.

Very soon, Cognivia customers will
have the opportunity to be even faster,

sharper and more alert. Imagine
the difference it could make to your life.

Natural
selection

Before we move forward in our
development, we want to be absolutely sure that

weʼre heading in the right
direction. Thatʼs why weʼre taking a little more time

to perfect Ceretin 6, making
certain that we understand any test anomalies.

The testing phase is designed to
highlight issues as early as possible. It is doing

exactly that. Rather than worry
about the extended test process, we should be

glad that any imperfections have
been detected at a stage when we can study

and correct them.

The human race has waited millions
of years to reach this point. We can afford

to spend a few more months
sharpening our future.

-------

cnvc o g n i v i a Shareholder Update 

March 269

thinking ahead

This has been a great year for
Cognivia, in the face of challenging conditions.

Not only have we produced our best
ever financial results, but weʼve also laid

the foundations for future
success.

All our shareholders can feel
confident that their investment will continue to

grow, as we work to improve the
lives of our citizens in a financially responsible

manner.

Proof copies of the forthcoming C6
research paper will be available to CE professionals

in April 269.

For further
details, please contact us at media@cognivia.com or log into

your secure
account.

Cognivia Shareholder Update - Revision history

Scott at 19:52, 13 March 2007

Scott at 21:03, 21 April 2006

Scott at 16:57, 21 April 2006